Christoph Samuel Ziegler
Christoph Samuel Ziegler has made 1 open-market purchase worth $33k since Oct 21, 2026, in 1 company. The latest: $33k of VRXA, filed Oct 21, 2026, scored 34 out of 100.
Director, Veraxa Biotech AG - Post de-SPAC
Follow Christoph Samuel Ziegler, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Purchases
| Filed | Stock | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Oct 21 Form 4 (opens sec.gov) |
VRXAVeraxa Biotech AG - Post de-SPAC · DirectorDirector · Penny stock: hard to trade | +378% stake | 34 | $33k 30,000 at $1.09 |
+9.7% | waiting |
Track record (hypothetical): a week after the filing, these buys averaged +9.7% (100% up, 1 measured).
Questions
What stock has Christoph Samuel Ziegler bought?
VRXA (Veraxa Biotech AG - Post de-SPAC), all on the open market and reported on SEC Form 4.
When did Christoph Samuel Ziegler last buy?
Oct 21, 2026: 30,000 shares of VRXA at $1.09, $33k in all (Form 4 (opens sec.gov)).
Has Christoph Samuel Ziegler filed a notice of a planned sale?
Not in the filings on record. A Form 144 is the notice an insider must file before selling restricted or control shares, and it lands on EDGAR before the sale is reported.
Is Christoph Samuel Ziegler a routine or an opportunistic buyer?
There isn't enough history to say yet.
Data as of Oct 21, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer